Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes

Robert J. Ihry(Genomics Institute of the Novartis Research Foundation), Ajamete Kaykas(Metro Transit), Chaoyang Ye(Blueprint Medicines (United States)), John Reece-Hoyes(University of Massachusetts Chan Medical School), Daniel Ho(Novartis (United States)), Gregory McAllister, Max R. Salick(Novartis (United States)), Kathleen A. Worringer(Johns Hopkins University), Ranjit Randhawa(Novartis (United States)), Zinger Yang(Broad Institute), Joe Raymond(Novartis (United States)), Gregory R. Hoffman, Sravya Kommineni(Novartis (United States)), Marie Sondey(AbbVie (United States)), Qiong Wang(Shanghai Jiao Tong University), Ricardo Dolmetsch(Novartis (United States)), Steven Paula, Carsten Russ(Broad Institute), Robert C. Altshuler, Beata Henry, Elizabeth Frias(Novartis (United States))
Cell Reports
April 1, 2019
10.1016/j.celrep.2019.03.043
Cited by 81

Related Papers

Structure, function and diversity of the healthy human microbiome
|Nature|2012|12k
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
|Nature|2007|4.2k
Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity
|Cell|2014|2k
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
|Nature Biotechnology|2009|1.5k